First Header Logo Second Header Logo

Connection

Samuel Lentz to Nucleic Acid Synthesis Inhibitors

Back to Details
This is a "connection" page, showing publications Samuel Lentz has written about Nucleic Acid Synthesis Inhibitors.
Samuel Lentz
Connection Strength
0.014
Nucleic Acid Synthesis Inhibitors
  1. Plaxe SC, Blessing JA, Olt G, Husseinzadah N, Lentz SS, DeGeest K, Valea FA. A phase II trial of pyrazoloacridine (PZA) in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Cancer Chemother Pharmacol. 2002 Aug; 50(2):151-4.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.